PSTV- Plus Therapeutics, Inc.
Plus Therapeutics, Inc. (PSTV) has 7 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. PSTV is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 397.8K | $1.54M | - | |
| CEO | 339.8K | $1.31M | - | |
| Dir | 297.8K | $1.15M | - | |
| Dir | 297.8K | $1.15M | - | |
| Dir | 297.8K | $1.15M | - |
Activity
Buys and sells only
Transactions
10 filings · page 3
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Petersen Greg | Director | Buy | 20,000 | $1.70 | $34,062.00 | +480.1% | +40.0% | -16.0% | |
| Jun 6, 2023 | Clowes Howard | Director | Buy | 1,000 | $3.98 | $3,980.00 | +27.0% | -27.4% | -35.4% | |
| May 3, 2023 | Clowes Howard | Director | Buy | 2,500 | $3.64 | $9,101.50 | +208.3% | -33.3% | -52.0% | |
| Mar 3, 2023 | Hawkins Richard J | Director | Buy | 1 | $1,000.00 | $1,000.00 | New | -25.1% | -61.9% | |
| Dec 30, 2022 | Lenk Robert P50 | Director | Sell | 1,500 | $0.31 | $472.05 | -15.0% | -12.3% | -63.2% | |
| Jun 15, 2022 | Hedrick Marc H | Chief Executive Officer | Buy | 5,000 | $0.65 | $3,240.00 | +17.5% | +12.0% | -63.8% | |
| Jun 2, 2022 | Clowes Howard | Director | Buy | 15,000 | $0.57 | $8,589.00 | +500.0% | +48.8% | -53.5% | |
| May 17, 2022 | Petersen Greg | Director | Buy | 30,000 | $0.55 | $16,500.00 | +92.3% | +7.1% | -48.4% | |
| Apr 26, 2022 | Hedrick Marc H | Chief Executive Officer | Buy | 2,500 | $0.68 | $1,710.25 | +9.6% | -21.5% | -66.7% | |
| Apr 26, 2022 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Buy | 3,000 | $0.67 | $2,016.00 | +32.5% | -21.5% | -66.7% |